Close
Close
Treatment Database
Glyceryl tri-(4-phenylbutyrate)
Trade Name Ravicti
Orphan Indication Carbamoyl-phosphate synthase-1 deficiency
EU Market Approval 01-12-2015
EU Designation Date 10-06-2010
Sponsor Horizon Pharma Ireland Limited
More about Carbamoyl phosphate synthase 1 deficiency
Free Newsletter